Briefing
Double trouble: Synchronous and metachronous primaries confound ctHPVDNA monitoring.
The paper describes how a second HPV-positive primary, reported in about 7.4% of people with HPV-positive head and neck cancer, can confound circulating tumor HPV DNA monitoring.
- Design: Evidence level 3
- Assay: ctHPVDNA